Apollo economist flags years-long delay for AI gains in regulated sectors

The more pointed implication Slok raises isn't just about timeline slippage: it's that Wall Street has been pricing regulated-sector AI gains as if those sectors face the same deployment friction as a software company shipping a new API endpoint, which they structurally do not.

This connects directly to Platformer's July 2 piece on the widening gap between AI capability deployment and the institutional capacity to absorb it. That story framed the lag as a harm-mitigation problem; Slok reframes the same structural friction as a valuation problem, which is a meaningful extension of the same underlying dynamic. Regulatory drag in healthcare and banking isn't a new observation, but attaching it to specific repricing risk gives it sharper investment relevance. The broader context here is an AI economy where capital is being deployed at extraordinary scale, as the Meta compute spending stories from early July illustrate, while the actual productivity returns in regulated industries remain genuinely uncertain and far-dated.

Watch whether sell-side analysts at major banks begin revising sector-specific AI earnings contribution estimates for healthcare and financials in Q3 2026 earnings previews. If consensus estimates hold flat despite this kind of pushback from a credible macro voice, that itself signals how deeply the broad-based AI profit narrative is embedded in current models.